Results 111 to 120 of about 604,354 (307)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego   +10 more
wiley   +1 more source

The Financial Market: or How to Forecast Unforcastable (Book review: Milovidov V. D. "Symmetry of Delusions. Factors of Financial Market Uncertaincy and Technological Revolution")

open access: yesМодернизация, инновация, развитие, 2019
The Financial Market: How to Forecast Unforcastable (Book review: Milovidov V. D. Symmetry of Delusions. Factors of Financial Market Uncertaincy and Technological Revolution: Monograph)
M. K. Belyaev
doaj  

Evaluation of Precipitation Observations Across Ecuador

open access: yesAtmospheric Science Letters
Accurate precipitation observations are crucial for hydrological and climate monitoring, forecasting and research. However, sparse networks in regions with complex topography, like Ecuador, limit data availability.
Angela Iza‐Wong   +5 more
doaj   +1 more source

Evaluating a three-dimensional panel of point forecasts : the Bank of England survey of external forecasters [PDF]

open access: yes
This article provides a first analysis of the forecasts of inflation and GDP growth obtained from the Bank of England's Survey of External Forecasters, considering both the survey average forecasts published in the quarterly Inflation Report, and the ...
Boero, Gianna   +2 more
core   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

An improved estimate of daily precipitation from the ERA5 reanalysis

open access: yesAtmospheric Science Letters
Precipitation is an essential climate variable and a fundamental part of the global water cycle. Given its importance to society, precipitation is often assessed in climate monitoring activities, such as in those led by the Copernicus Climate Change ...
David A. Lavers   +3 more
doaj   +1 more source

Relative Accuracy of Judgmental and Extrapolative Methods in Forecasting Annual Earnings [PDF]

open access: yes
This paper identifies and analyses previously published studies on annual earnings forecasts. Comparisons of forecasts produced by management, analysts, and extrapolative techniques indicated that: (1) management forecasts were superior to professional ...
JS Armstrong
core  

Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion

open access: yes
Pediatric Blood &Cancer, EarlyView.
Marllon Cindra Sant'Ana   +8 more
wiley   +1 more source

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Treatment‐associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children's Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele
Emily J. Mason   +14 more
wiley   +1 more source

Forecasts 1983 [PDF]

open access: yes
An abstract for this article is not available ...
Roy H. Webb
core  

Home - About - Disclaimer - Privacy